Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.

Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, MacDonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW.

Neuro Oncol. 2018 Oct 9;20(11):1547-1555. doi: 10.1093/neuonc/noy070.

2.

Localized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive liposomes.

Bredlau AL, Motamarry A, Chen C, McCrackin MA, Helke K, Armeson KE, Bynum K, Broome AM, Haemmerich D.

Drug Deliv. 2018 Nov;25(1):973-984. doi: 10.1080/10717544.2018.1461280.

3.

The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD; Huntington Study Group CREST-E Investigators and Coordinators.

Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.

4.

Bevacizumab Therapy for Pilomyxoid Astrocytoma.

Metts RD, Bartynski W, Welsh CT, Kinsman S, Bredlau AL.

J Pediatr Hematol Oncol. 2017 May;39(4):e219-e223. doi: 10.1097/MPH.0000000000000824.

PMID:
28338567
5.

Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity.

Das A, McDonald D, Lowe S, Bredlau AL, Vanek K, Patel SJ, Cheshier S, Eskandari R.

Childs Nerv Syst. 2017 Mar;33(3):429-436. doi: 10.1007/s00381-016-3305-x. Epub 2016 Dec 9.

PMID:
27942918
6.

Subcortical DNET in a Patient With an Enzymatic Deficiency: A Rare Case and Review of the Literature.

Infinger LK, Karia SR, Kinsman SL, Kosnik EJ, Welsh CT, Roberts DR, Bredlau AL.

J Pediatr Hematol Oncol. 2016 Nov;38(8):e291-e294. Review.

PMID:
27271814
7.

Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.

Miller K, Dixit S, Bredlau AL, Moore A, McKinnon E, Broome AM.

Nanomedicine (Lond). 2016 Mar;11(6):581-95. doi: 10.2217/nnm.15.218. Epub 2016 Mar 22.

8.

A PIECE OF MY MIND. Where Do You Put the Pain?

Bredlau AL.

JAMA. 2016 Mar 8;315(10):983. doi: 10.1001/jama.2015.17474. No abstract available.

PMID:
26954404
9.

Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.

Bredlau AL, Dixit S, Chen C, Broome AM.

Curr Neuropharmacol. 2017;15(1):104-115. Review.

10.

Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.

Bredlau AL, McCrackin MA, Motamarry A, Helke K, Chen C, Broome AM, Haemmerich D.

Crit Rev Biomed Eng. 2016;44(6):443-457. doi: 10.1615/CritRevBiomedEng.2017021249.

11.

Neurocognitive Changes after Sustained Ketamine Administration in Children with Chronic Pain.

Bredlau AL, Harel BT, McDermott MP, Dworkin RH, Korones DN, Dolan JG, Adams HR.

J Palliat Care Med. 2015 Mar;5(2). pii: 215. Epub 2015 Mar 27.

12.

Diffuse intrinsic pontine gliomas: treatments and controversies.

Bredlau AL, Korones DN.

Adv Cancer Res. 2014;121:235-259. doi: 10.1016/B978-0-12-800249-0.00006-8. Review.

PMID:
24889533
13.

Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature.

Bredlau AL, Thakur R, Korones DN, Dworkin RH.

Pain Med. 2013 Oct;14(10):1505-17. doi: 10.1111/pme.12182. Epub 2013 Aug 5. Review.

PMID:
23915253
14.

Oral ketamine for children with chronic pain: a pilot phase 1 study.

Bredlau AL, McDermott MP, Adams HR, Dworkin RH, Venuto C, Fisher SG, Dolan JG, Korones DN.

J Pediatr. 2013 Jul;163(1):194-200.e1. doi: 10.1016/j.jpeds.2012.12.077. Epub 2013 Feb 10.

15.

Incidental brain lesions in children: to treat or not to treat?

Bredlau AL, Constine LS, Silberstein HJ, Milano MT, Korones DN.

J Neurooncol. 2012 Feb;106(3):589-94. doi: 10.1007/s11060-011-0695-1. Epub 2011 Aug 19.

PMID:
21853423
16.

Management of immune thrombocytopenic purpura in children: potential role of novel agents.

Bredlau AL, Semple JW, Segel GB.

Paediatr Drugs. 2011 Aug 1;13(4):213-23. doi: 10.2165/11591640-000000000-00000. Review.

PMID:
21692546

Supplemental Content

Loading ...
Support Center